Zhang, J., Ding, M., Nan, F., Fu, X., Chang, Y., Zhang, L., Zhang, M., Zhang, X. (2025). Real-world analysis of axicabtagene ciloleucel (axi-cel) as consolidation therapy following first-line treatment in B-cell lymphoma with high-risk factors. Blood. https://doi.org/10.1182/blood-2025-8015